Abstract
Lentiviral Gene Therapy with Low Dose Busulfan for Infants with X-SCID Results in the Development of a Functional Normal Immune System: Interim Results of an Ongoing Phase I/II Clinical Study
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have